About this episode
The episode discusses the multibillion-dollar exposure companies face from mass tort personal-injury litigation and the major hurdles they encounter.
Companies facing multibillion-dollar exposure from mass tort personal-injury litigation have faced massive jury verdicts in 2026, and the trend shows no sign of slowing. In this Votes and Verdicts episode, BI litigation analysts Holly Froum and Matthew Schettenhelm are joined by mass tort expert Joseph Fantini to discuss some of the major hurdles facing companies, including weedkiller cancer claims against Bayer’s Monsanto, NEC litigation against Abbott and Reckitt’s Mead Johnson unit, talc litigation against Johnson & Johnson, social-media addiction lawsuits against Meta, Google and others, and more. They discuss potential catalysts on the horizon, the strength of cases and the likelihood of any global settlements. See omnystudio.com/listener for privacy information.
People in this episode
Hosts: Holly Froum, Matthew Schettenhelm
Guest: Joseph Fantini
Topics covered
- mass tort litigation
- personal injury
- corporate liability
- jury verdicts
- legal challenges
- settlements
Keywords
- mass tort
- Bayer
- Abbott
- Johnson & Johnson
- litigation
- jury verdicts
- settlements
- legal challenges
- personal injury
Mentioned in this episode
Organizations: Bayer, Abbott, Johnson & Johnson, Meta, Google, Reckitt, Monsanto, Mead Johnson
More episodes of Votes & Verdicts
- Marijuana Rescheduling in Washington · June 12, 2026 · 39 min
- Bayer Appeal of Roundup Suits at Supreme Court · June 5, 2026 · 29 min
- Social Media Addicts, Seed Antitrust, AI Tax · May 29, 2026 · 27 min
- Joyce Adetutu on Tariff Risks, Refunds · May 22, 2026 · 25 min
- Can Trump Fix the Housing Affordability Pinch? · May 15, 2026 · 44 min
- Why Mortgage Rates Are Stuck Above 6% · May 8, 2026 · 50 min
Explore listener stats, chart rankings, contacts and more on the Votes & Verdicts podcast page.